Your browser doesn't support javascript.
loading
Autophagy as a molecular target for cancer treatment.
Kocaturk, Nur Mehpare; Akkoc, Yunus; Kig, Cenk; Bayraktar, Oznur; Gozuacik, Devrim; Kutlu, Ozlem.
Affiliation
  • Kocaturk NM; Sabanci University Nanotechnology Research and Application Center (SUNUM), Istanbul 34956, Turkey.
  • Akkoc Y; Faculty of Engineering and Natural Sciences, Molecular Biology, Genetics and Bioengineering Program, Sabanci University, Istanbul 34956, Turkey.
  • Kig C; Faculty of Medicine, Istanbul Yeni Yuzyil University, Zeytinburnu, 34010 Istanbul, Turkey.
  • Bayraktar O; Faculty of Medicine, Department of Medical Biology and Genetic, Okan University, Istanbul, Turkey.
  • Gozuacik D; Sabanci University Nanotechnology Research and Application Center (SUNUM), Istanbul 34956, Turkey; Faculty of Engineering and Natural Sciences, Molecular Biology, Genetics and Bioengineering Program, Sabanci University, Istanbul 34956, Turkey.
  • Kutlu O; Sabanci University Nanotechnology Research and Application Center (SUNUM), Istanbul 34956, Turkey. Electronic address: ozlemkutlu@sabanciuniv.edu.
Eur J Pharm Sci ; 134: 116-137, 2019 Jun 15.
Article in En | MEDLINE | ID: mdl-30981885
Subject(s)
Key words
3-MethylAdenine(3-MA) (PubChem CID: 1673); 5-Fluorouracil (5-FU) (PubChem CID: 3385); Allicin (PubChem CID: 65036); Apatinib (PubChem CID: 45139106); Arsenic trioxide (As(2)O(3)) (PubChem CID: 14888); Autophagy; Bafilomycin A1 (PubChem CID: 6436223); Bortezomib (PubChem CID: 387447); Brefeldin A (PubChem CID: 5287620); Camptothecin (PubChem CID: 24360); Cancer; Chloroquine (PubChem CID: 64927); Cisplatin (PubChem CID: 5702198); Curcumin (PubChem CID: 969516); Diethylnitrosamine (DEN) (PubChem CID: 5921); Epigallocatechin gallate (EGCG) (PubChem CID: 65064); Erlotinib (PubChem CID: 176870); Everolimus (PubChem CIDL: 6442177); Gefitinib (PubChem CID: 123631); Ginsenoside F2 (PubChem CID: 9918692); Ginsenoside Rb1 (PubChem CID: 9898279); Hidroxychloroquine (PubChem CID: 3652); Imatinib (PubChem CID:5291); LY294002 (PubChem CID: 3973); Lapatinib (PubChem CID: 208908); Monensin (PubChem CID: 441145); NVP-BEZ235 (PubChem CID: 11977753); Polygonatum cyrtonema lectin (PCL) (PubChem SID: 103031201); Quinazolinediamine (QZN) (PubChem CID: 65087); Rapamycin (PubChem CID: 62969); Resveratrol (PubChem CID: 445154); Ridaforolimus (PubChem CID: 11520894); Romidepsin (PubChem CID: 5352062); SAR405 (PubChem CID: 72709209); Scutellarein (PubChem CID: 185617); Sertraline (PubChem CID: 68617); Sorafenib (PubChem CID: 216239); Spautin-1 (PubChem CID: 51037431); Spermidine (PubChem CID: 1102); Suberoylanilide Hydroxamic acid (SAHA) (PubChem CID: 5311); Tamoxifen (PubChem CID: 2733526); Temozolomide (PubChem CID: 5394); Temsirolimus (PubChem CID: 86277830); Therapeutic agents; Trastuzumab (PubChem CID: 96849); Vandetanib (PubChem CID: 3081361); Varinostat (PubChem CID: 5311); Vinblastine (PubChem CID: 13342); Viridiol (PubChem CID: 5459246); Wortmannin (PubChem CID: 312145)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Autophagy / Neoplasms Language: En Journal: Eur J Pharm Sci Year: 2019 Type: Article Affiliation country: Turkey
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Autophagy / Neoplasms Language: En Journal: Eur J Pharm Sci Year: 2019 Type: Article Affiliation country: Turkey